230 related articles for article (PubMed ID: 6375469)
1. Effects of flunarizine and pentoxifylline on walking distance and blood rheology in claudication.
Perhoniemi V; Salmenkivi K; Sundberg S; Johnsson R; Gordin A
Angiology; 1984 Jun; 35(6):366-72. PubMed ID: 6375469
[TBL] [Abstract][Full Text] [Related]
2. The effects of physical training and flunarizine on walking capacity in intermittent claudication.
Lepäntalo M; Sundberg S; Gordin A
Scand J Rehabil Med; 1984; 16(4):159-62. PubMed ID: 6397852
[TBL] [Abstract][Full Text] [Related]
3. Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication.
Dawson DL; Zheng Q; Worthy SA; Charles B; Bradley DV
Angiology; 2002; 53(5):509-20. PubMed ID: 12365857
[TBL] [Abstract][Full Text] [Related]
4. A controlled trial of pentoxifylline (Trental 400) in intermittent claudication: clinical, haemostatic and rheological effects.
Reilly DT; Quinton DN; Barrie WW
N Z Med J; 1987 Jul; 100(828):445-7. PubMed ID: 3330188
[TBL] [Abstract][Full Text] [Related]
5. [Flunarizine in the treatment of arteriopathies of the legs].
Catalano M; Sacchi E; Tomasini M; Coazzoli E; Parolini A; Dall'Oglio A; Libretti A
Ric Clin Lab; 1985; 15 Suppl 1():475-8. PubMed ID: 4035228
[TBL] [Abstract][Full Text] [Related]
6. Acenocoumarol and pentoxifylline in intermittent claudication. A controlled clinical study. The APIC Study Group.
Dettori AG; Pini M; Moratti A; Paolicelli M; Basevi P; Quintavalla R; Manotti C; Di Lecce C
Angiology; 1989 Apr; 40(4 Pt 1):237-48. PubMed ID: 2650578
[TBL] [Abstract][Full Text] [Related]
7. Intermittent claudication: a double-blind crossover trial of pentoxifylline.
Gallus AS; Gleadow F; Dupont P; Walsh J; Morley AA; Wenzel A; Alderman M; Chivers D
Aust N Z J Med; 1985 Aug; 15(4):402-9. PubMed ID: 3866536
[TBL] [Abstract][Full Text] [Related]
8. Placebo controlled double blind study with pentoxifylline of walking performance in patients with intermittent claudication.
Di Perri T; Guerrini M
Angiology; 1983 Jan; 34(1):40-5. PubMed ID: 6824189
[TBL] [Abstract][Full Text] [Related]
9. The rheological effects of cinnarizine and flunarizine in normal and pathologic conditions.
De Cree J; De Cock W; Geukens H; De Clerck F; Beerens M; Verhaegen H
Angiology; 1979 Aug; 30(8):505-15. PubMed ID: 380411
[No Abstract] [Full Text] [Related]
10. Effects of pentoxifylline on severe intermittent claudication.
Reich T; Gillings D
Angiology; 1987 Sep; 38(9):651-6. PubMed ID: 3310744
[TBL] [Abstract][Full Text] [Related]
11. Does oxpentifylline ('Trental') have a place in the treatment of intermittent claudication?
Donaldson DR; Hall TJ; Kester RC; Ramsden CW; Wiggins PA
Curr Med Res Opin; 1984; 9(1):35-40. PubMed ID: 6373157
[TBL] [Abstract][Full Text] [Related]
12. [Intermittent claudication treated with pentoxifylline. A controlled trial].
Skovborg F; Bonde-Petersen F; Bloch I; Christensen E
Ugeskr Laeger; 1983 Nov; 145(47):3649-52. PubMed ID: 6362159
[No Abstract] [Full Text] [Related]
13. Differential effects of cilostazol and pentoxifylline on vascular endothelial growth factor in patients with intermittent claudication.
Lee TM; Su SF; Tsai CH; Lee YT; Wang SS
Clin Sci (Lond); 2001 Sep; 101(3):305-11. PubMed ID: 11524048
[TBL] [Abstract][Full Text] [Related]
14. Treatment of long-distance intermittent claudication with pentoxifylline: a 12-month, randomized trial.
De Sanctis MT; Cesarone MR; Belcaro G; Nicolaides AN; Griffin M; Incandela L; Bucci M; Geroulakos G; Ramaswami G; Vasdekis S; Agus G; Bavera P; Ippolito E
Angiology; 2002; 53 Suppl 1():S13-7. PubMed ID: 11865829
[TBL] [Abstract][Full Text] [Related]
15. Treatment of intermittent claudication with pentoxifylline: a 12-month, randomized trial--walking distance and microcirculation.
De Sanctis MT; Cesarone MR; Belcaro G; Nicolaides AN; Griffin M; Incandela L; Bucci M; Geroulakos G; Ramaswami G; Vasdekis S; Agus G; Bavera P; Ippolito E
Angiology; 2002; 53 Suppl 1():S7-12. PubMed ID: 11865838
[TBL] [Abstract][Full Text] [Related]
16. Intravenous treatment of chronic peripheral occlusive arterial disease: a double-blind, placebo-controlled, randomized, multicenter trial of pentoxifylline.
Rudofsky G; Haussler KF; Künkel HP; Schneider-May H; Spengel F; Symann O; Werner HJ
Angiology; 1989 Jul; 40(7):639-49. PubMed ID: 2662830
[TBL] [Abstract][Full Text] [Related]
17. Treatment of claudication with pentoxifylline: are benefits related to improvement in viscosity?
Johnson WC; Sentissi JM; Baldwin D; Hamilton J; Dion J
J Vasc Surg; 1987 Sep; 6(3):211-6. PubMed ID: 3625877
[TBL] [Abstract][Full Text] [Related]
18. Clinical and microcirculatory effects of transcutaneous CO2 therapy in intermittent claudication. Randomized double-blind clinical trial with a parallel design.
Fabry R; Monnet P; Schmidt J; Lusson JR; Carpentier PH; Baguet JC; Dubray C
Vasa; 2009 Aug; 38(3):213-24. PubMed ID: 19736632
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of pentoxifylline, buflomedil, and nifedipine in the treatment of intermittent claudication of the lower limbs.
Chacón-Quevedo A; Eguaras MG; Calleja F; Garcia MA; Roman M; Casares J; Muñoz I; Concha M
Angiology; 1994 Jul; 45(7):647-53. PubMed ID: 8024164
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of pentoxifylline in geriatric patients with intermittent claudication.
Crowder JE; Cohn JB; Savitsky JP; Morgan DL; Slywka J; Cobert BL; Hryniewicki SW; Piccirillo RT; Wilcox CS
Angiology; 1989 Sep; 40(9):795-802. PubMed ID: 2669564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
